Trial-In-Progress Looks to Prophylactic Tocilizumab to Reduce CRS in Patients with Multiple Myeloma
1 year ago
42
- Homepage
- category-label-
- Trial-In-Progress Looks to Prophylactic Tocilizumab to Reduce CRS in Patients with Multiple Myeloma
Related
Trending
Popular
Reduce your risk of cancer: get involved and have fun
1 year ago
227
Copyright © 2019 - 2025 | Whatiscancer.net | All Rights Reserved.







English (US) ·